<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02268955</url>
  </required_header>
  <id_info>
    <org_study_id>2014-067</org_study_id>
    <nct_id>NCT02268955</nct_id>
  </id_info>
  <brief_title>Analgesic Efficacy of Intravenous Ibuprofen in Biliary Colic</brief_title>
  <official_title>Assessment of the Analgesic Efficacy of Intravenous Ibuprofen in Biliary Colic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Valleywise Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Valleywise Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess the analgesic efficacy of intravenous ibuprofen given in
      the Emergency Department for the treatment of biliary colic. We hypothesize that intravenous
      ibuprofen will provide a clinically significant drop in self-reported patient pain level as
      measured by the visual analog scale.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is estimated over 20 million people aged 20-74 have gallbladder disease, with biliary
      colic being a common and painful symptom in these patients. Likely due to the relatively
      recent approval of intravenous ibuprofen use for fever and pain in adults, no assessment of
      its analgesic efficacy for biliary colic currently exists in the literature.

      Utilizing a visual analog scale (VAS) for patient self-assessment of pain, this study will
      address this lack of evidence and identify intravenous ibuprofen's value as a novel analgesic
      in the treatment of biliary colic. Patients will be given a VAS at the time of study therapy
      administration, at 15-minute intervals during the first hour post-administration, and
      30-minute intervals in the second hour. Though NSAID's have been extensively studied in the
      management of this phenomenon, this study aims to help optimize pain treatment of patients
      presenting to the Emergency Department with biliary colic, and potentially pave the way for
      future analgesic treatment comparison studies.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 9, 2014</start_date>
  <completion_date type="Actual">June 28, 2017</completion_date>
  <primary_completion_date type="Actual">June 21, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Score 120 Minutes After Study Medication Administration</measure>
    <time_frame>120 minutes post medication administration</time_frame>
    <description>Pain is measured on a visual analog scale 0=no pain and 10=worst pain imaginable.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Biliary Colic</condition>
  <arm_group>
    <arm_group_label>Control Group: Adults age 18-55 years</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline-only control group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IV Ibuprofen: Adults age 18-55 years</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receiving intravenous ibuprofen therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV Ibuprofen</intervention_name>
    <description>Intravenous ibuprofen will be administered for treatment of pain in adults presenting to the ED with biliary colic</description>
    <arm_group_label>IV Ibuprofen: Adults age 18-55 years</arm_group_label>
    <other_name>Caldolor</other_name>
    <other_name>NeoProfen</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Saline will be administered to the placebo group</description>
    <arm_group_label>Control Group: Adults age 18-55 years</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients ages 18-55

          -  Present to ED with right upper quadrant (RUQ) abdominal pain

          -  Suspected diagnosis of biliary colic

          -  Negative pregnancy test for women of childbearing potential (complete POC testing
             form)

          -  No history of cholecystectomy

        Exclusion Criteria:

          -  Patient age &lt; 18 or &gt; 55

          -  Incarcerated

          -  Hemodynamic instability

          -  Inability to reliably self-report or communicate pain intensity and pain relief

          -  Taking Warfarin

          -  Cannot consent of are not competent to consent

          -  Hepatic, renal, cardiac failure

          -  NSAID or morphine allergy

          -  History congenital bleeding diathesis or platelet dysfunction

          -  Peptic ulcer diseases

          -  Are otherwise unsuitable for the study in the opinion of the
             investigator/sub-investigators
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dan Quan, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Valleywise Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maricopa Integrated Health System</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85008</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Promes JT, Safcsak K, Pavliv L, Voss B, Rock A. A prospective, multicenter, randomized, double-blind trial of IV ibuprofen for treatment of fever and pain in burn patients. J Burn Care Res. 2011 Jan-Feb;32(1):79-90. doi: 10.1097/BCR.0b013e3182037300.</citation>
    <PMID>21127424</PMID>
  </reference>
  <reference>
    <citation>Jensen MP, Chen C, Brugger AM. Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain. J Pain. 2003 Sep;4(7):407-14.</citation>
    <PMID>14622683</PMID>
  </reference>
  <reference>
    <citation>Krudsood S, Tangpukdee N, Wilairatana P, Pothipak N, Duangdee C, Warrell DA, Looareesuwan S. Intravenous ibuprofen (IV-ibuprofen) controls fever effectively in adults with acute uncomplicated Plasmodium falciparum malaria but prolongs parasitemia. Am J Trop Med Hyg. 2010 Jul;83(1):51-5. doi: 10.4269/ajtmh.2010.09-0621.</citation>
    <PMID>20595477</PMID>
  </reference>
  <reference>
    <citation>Morris PE, Promes JT, Guntupalli KK, Wright PE, Arons MM. A multi-center, randomized, double-blind, parallel, placebo-controlled trial to evaluate the efficacy, safety, and pharmacokinetics of intravenous ibuprofen for the treatment of fever in critically ill and non-critically ill adults. Crit Care. 2010;14(3):R125. doi: 10.1186/cc9089. Epub 2010 Jun 30.</citation>
    <PMID>20591173</PMID>
  </reference>
  <reference>
    <citation>Singla N, Rock A, Pavliv L. A multi-center, randomized, double-blind placebo-controlled trial of intravenous-ibuprofen (IV-ibuprofen) for treatment of pain in post-operative orthopedic adult patients. Pain Med. 2010 Aug;11(8):1284-93. doi: 10.1111/j.1526-4637.2010.00896.x. Epub 2010 Jun 30.</citation>
    <PMID>20609131</PMID>
  </reference>
  <reference>
    <citation>Kroll PB, Meadows L, Rock A, Pavliv L. A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen (i.v.-ibuprofen) in the management of postoperative pain following abdominal hysterectomy. Pain Pract. 2011 Jan-Feb;11(1):23-32. doi: 10.1111/j.1533-2500.2010.00402.x.</citation>
    <PMID>20642488</PMID>
  </reference>
  <reference>
    <citation>Southworth S, Peters J, Rock A, Pavliv L. A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain. Clin Ther. 2009 Sep;31(9):1922-35. doi: 10.1016/j.clinthera.2009.08.026.</citation>
    <PMID>19843482</PMID>
  </reference>
  <reference>
    <citation>Smith HS, Voss B. Pharmacokinetics of intravenous ibuprofen: implications of time of infusion in the treatment of pain and fever. Drugs. 2012 Feb 12;72(3):327-37. doi: 10.2165/11599230-000000000-00000. Review.</citation>
    <PMID>22316349</PMID>
  </reference>
  <reference>
    <citation>Colli A, Conte D, Valle SD, Sciola V, Fraquelli M. Meta-analysis: nonsteroidal anti-inflammatory drugs in biliary colic. Aliment Pharmacol Ther. 2012 Jun;35(12):1370-8. doi: 10.1111/j.1365-2036.2012.05115.x. Epub 2012 Apr 29.</citation>
    <PMID>22540869</PMID>
  </reference>
  <reference>
    <citation>Henderson SO, Swadron S, Newton E. Comparison of intravenous ketorolac and meperidine in the treatment of biliary colic. J Emerg Med. 2002 Oct;23(3):237-41.</citation>
    <PMID>12426013</PMID>
  </reference>
  <reference>
    <citation>Olsen JC, McGrath NA, Schwarz DG, Cutcliffe BJ, Stern JL. A double-blind randomized clinical trial evaluating the analgesic efficacy of ketorolac versus butorphanol for patients with suspected biliary colic in the emergency department. Acad Emerg Med. 2008 Aug;15(8):718-22. doi: 10.1111/j.1553-2712.2008.00178.x. Epub 2008 Jul 11.</citation>
    <PMID>18637080</PMID>
  </reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>October 16, 2014</study_first_submitted>
  <study_first_submitted_qc>October 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2014</study_first_posted>
  <results_first_submitted>January 29, 2018</results_first_submitted>
  <results_first_submitted_qc>April 25, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">May 14, 2019</results_first_posted>
  <last_update_submitted>April 25, 2019</last_update_submitted>
  <last_update_submitted_qc>April 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Biliary Colic</keyword>
  <keyword>Abdominal pain</keyword>
  <keyword>Intravenous Ibuprofen</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 5, 2014</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/55/NCT02268955/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Control Group</title>
          <description>Saline-only control group
Saline: Saline will be administered to the placebo group</description>
        </group>
        <group group_id="P2">
          <title>IV Ibuprofen</title>
          <description>Patients receiving intravenous ibuprofen therapy
IV Ibuprofen: Intravenous ibuprofen will be administered for treatment of pain in adults presenting to the ED with biliary colic</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Baseline data for the population is VAS pain score prior to Intravenous Ibuprofen or Placebo administration.</population>
      <group_list>
        <group group_id="B1">
          <title>Control Group</title>
          <description>Saline-only control group
Saline: Saline will be administered to the placebo group</description>
        </group>
        <group group_id="B2">
          <title>IV Ibuprofen</title>
          <description>Patients receiving intravenous ibuprofen therapy
IV Ibuprofen: Intravenous ibuprofen will be administered for treatment of pain in adults presenting to the ED with biliary colic</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="11"/>
            <count group_id="B2" value="11"/>
            <count group_id="B3" value="22"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <description>Ages 18-55 were enrolled. Individual subject's age data was not reported.</description>
          <population>Age for subjects analyzed.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>18-55 years of age</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                    <count group_id="B2" value="9"/>
                    <count group_id="B3" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>Male or Female for participants analyzed.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="11"/>
                    <count group_id="B2" value="11"/>
                    <count group_id="B3" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pain score</title>
          <description>Visual Analog pain score where 0=no pain, and 10=worse pain imaginable.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="11"/>
                    <count group_id="B2" value="11"/>
                    <count group_id="B3" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5" spread="0.015"/>
                    <measurement group_id="B2" value="6" spread="0.029"/>
                    <measurement group_id="B3" value="6" spread="0.001"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain Score 120 Minutes After Study Medication Administration</title>
        <description>Pain is measured on a visual analog scale 0=no pain and 10=worst pain imaginable.</description>
        <time_frame>120 minutes post medication administration</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control Group: Adults Age 18-55 Years</title>
            <description>Saline-only control group
Saline: Saline will be administered to the placebo group</description>
          </group>
          <group group_id="O2">
            <title>IV Ibuprofen: Adults Age 18-55 Years</title>
            <description>Patients receiving intravenous ibuprofen therapy
IV Ibuprofen: Intravenous ibuprofen will be administered for treatment of pain in adults presenting to the ED with biliary colic</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Score 120 Minutes After Study Medication Administration</title>
          <description>Pain is measured on a visual analog scale 0=no pain and 10=worst pain imaginable.</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0" lower_limit="0.0" upper_limit="7.0"/>
                    <measurement group_id="O2" value="0.3" lower_limit="0.0" upper_limit="8.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>During study treatment (about 2 hours).</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Control Group</title>
          <description>Saline-only control group
Saline: Saline will be administered to the placebo group</description>
        </group>
        <group group_id="E2">
          <title>IV Ibuprofen</title>
          <description>Patients receiving intravenous ibuprofen therapy
IV Ibuprofen: Intravenous ibuprofen will be administered for treatment of pain in adults presenting to the ED with biliary colic</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>There were not enough patients enrolled.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dan Quan, DO</name_or_title>
      <organization>Maricopa Integrated Health System</organization>
      <phone>602-344-5058</phone>
      <email>dany_quan@dmgaz.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

